Seres Therapeutics Inc To Discuss SER-109 Approval Call Transcript
Good day, and welcome to the Seres Therapeutics Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Dr. Carlo Tanzi, Head of Investor Relations. Please go ahead, sir.
Thank you, and good morning. Our press release for the approval of VOWST became available yesterday evening and can be found on the Investors and News section of the company's website. We have posted slides accompanying this call on the Seres website, and I encourage you to view those during the presentation.
I'll also remind you that we will be making forward-looking statements, including the availability of VOWST product supply, the degree of market adoption, penetration and accessibility, the results of payer engagement, the overall potential of microbiome therapeutics, the potential of future milestones, the ability of cash to fund operations and other statements which are not historical fact.
Actual results may differ materially. Additionally, these statements are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
